India  

Adar Poonawalla

Indian businessman

Adar Poonawalla    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Adar Poonawalla: Indian businessman
Adar Poonawalla is the chief executive officer (CEO) of Serum Institute of India. Founded in 1966 by his father, Cyrus Poonawalla, it is the world's largest vaccine manufacturer by number of doses produced.

0
shares
ShareTweetSavePostSend
 

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge [Video]

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge

Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over..

Credit: HT Digital Content     Duration: 02:05Published
Who threatened him?, asks Nana Patole on Adar Poonawalla's threat claims [Video]

Who threatened him?, asks Nana Patole on Adar Poonawalla's threat claims

During an interview to a London newspaper, head of Serum Institute of India (SII) Adar Poonawalla, who is one of the vaccine manufacturers in India, revealed that he is receiving threats from big..

Credit: ANI     Duration: 01:36Published
‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls [Video]

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls

Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a..

Credit: HT Digital Content     Duration: 01:50Published
‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India [Video]

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India

Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country..

Credit: HT Digital Content     Duration: 01:43Published
Adar Poonawalla 'life threat' | SII CEO gets Y security cover | Oneindia News [Video]

Adar Poonawalla 'life threat' | SII CEO gets Y security cover | Oneindia News

Amid threats to his life over Covishield vaccine supplies, the CEO of Serum Institute of India, the world's largest vaccine maker, has got Y category security. The centre granted SII CEO Adar..

Credit: Oneindia     Duration: 01:30Published
Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states [Video]

Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for states

Serum Institute of India reduced the vaccine price for the state government from Rs 400 per dose to Rs 300 per dose. SII chairman Adar Poonawalla announced on Twitter a reduction in prices...

Credit: HT Digital Content     Duration: 01:27Published

You Might Like


Plea in Bombay HC seeks Z-plus security for SII CEO Adar Poonawalla


IndiaTimes - Published

Not possible to ramp up vaccine production overnight: SII CEO Adar Poonawala

Serum Institute of India (SII) CEO Adar Poonawala on Monday said it is not possible to ramp up vaccine production overnight.Amid the ferocious second wave gripping India, Poonawala said "vaccine..
IndiaTimes - Published

Congress assures security to Adar Poonawalla, urges him to name leaders who made threat calls

Maharashtra Congress chief Nana Patole urged Poonawalla to make the names of those leaders public, adding that his party takes full responsibility for his security.
IndiaTimes - Published

Serum Institute of India CEO Adar Poonawalla makes BIG statement over COVID-19 vaccine shortage

According to a Financial Times report, SII CEO said that production of vaccines would increase in July from about 60-70 million to 100mln per month.
DNA - Published

Serum Institute CEO Adar Poonawalla: Will return to India in a few days

"Had an excellent meeting with all our partners & stakeholders in the UK. Meanwhile, pleased to state that Covishiled's production is in full swing in Pune. I look forward to reviewing operations upon..
IndiaTimes - Published

Serum Institute of India CEO Adar Poonawalla flies to London to after receiving 'threats' from CMs, corporates leaders

Poonawalla said that he is planning to stay in the UK for a long time because of constant threats he's getting from CMs and other corporate leaders.
DNA - Published

Covishield production in full swing, says SII's Adar Poonawalla


IndiaTimes - Published

'Getting aggressive calls from powerful people': Serum CEO Adar Poonawalla on vaccine pressure

Referring to the phone calls, Poonawala said "Threats is an understatement. The level of expectation and aggression is really unprecedented. It's overwhelming. Everyone feels they should get the..
IndiaTimes - Published

Serum Institute plans to start Covid vaccine production outside India: Report

The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief..
IndiaTimes - Published

Serum Institute CEO Adar Poonawalla gets 'Y' category security cover


IndiaTimes - Published

Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose

Serum Institute of India on Wednesday announced that it was reducing the price of its Covishield vaccine from Rs 400 to Rs 300 per dose for the states as a "philanthropic gesture". "As a philanthropic..
IndiaTimes - Published

Covid-19: Most vaccines may cost 700-1,000 per dose

Most companies are expected to price the Covid-19 vaccines around Rs 700-1,000 per dose, when they roll out the jabs in the private market later this year, up from the government-mandated price of Rs..
IndiaTimes - Published

Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of Covid-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year.
IndiaTimes - Published

Adar Poonawalla urges countries to be patient, says Serum directed to prioritise India needs

Adar Poonawalla, CEO of vaccine major Serum Institute of India (SII), on Sunday urged other countries to be patient as they wait for the supplies of Covid-19 vaccine, Covishield, as the company has..
IndiaTimes - Published

India's Serum says will ship AstraZeneca vaccine to Canada in 'less than a month'

The Serum Institute of India will ship the Oxford University/AstraZeneca Covid-19 vaccine to Canada in less than one month, Serum's chief executive said on Monday. "As we await regulatory approvals..
IndiaTimes - Published

Serum Institute of India plans to launch Covovax by June: Adar Poonawalla

SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch..
IndiaTimes - Published

COVID-19: Is India to get one more coronavirus vaccine, here's what SII CEO Adar Poonawalla said

The vaccine is being developed in partnership with American vaccine developer Novavax.
DNA - Published

Serum Institute applies to conduct local trial for Novavax vaccine: CEO

The Serum Institute of India (SII), the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc's COVID-19 vaccine, which was found to be 89.3%..
IndiaTimes - Published

SII to send 3m Covid shots to Saudi in a week: Poonawalla


IndiaTimes - Published

Serum fire losses pegged at over Rs 1,000 crore; Covid vaccine supplies safe

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said its manufacturing plant at Manjari here suffered a loss of over Rs1,000 crore in Thursday’s fire that claimed five lives.
IndiaTimes - Published

Serum Institute fire: Vaccine supply won't be affected, says CEO Adar Poonawalla


IndiaTimes - Published

Serum Institute fire: Adar Poonawalla explains why he tweeted, 'no lives lost'

Adar Poonawalla has given an explanation on his tweet that he did after fire broke out at Serum Institute's facility in Pune on Thursday afternoon.
DNA - Published

Adar Poonawalla reassures Covishield production won't be affected, tweets 'no lives lost' in SII fire

A major fire broke out at a building inside Terminal Gate 1 of the Serum Institute of India (SII) in Maharashtra's Pune on Thursday afternoon.
DNA - Published

COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here

Serum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that 'Covishield' will be made available in private markets at Rs 1,000.
DNA - Published

Covishield to cost Rs 1000 per vial in private market: SII CEO Adar Poonawalla

"We have given a special price of Rs 200 for the first 100 million doses only to the Government of India on their request, because we want to support common man, vulnerable, poor and healthcare..
IndiaTimes - Published

Brazil dials India on Covid vaccine imports

India’s vaccine diplomacy push might be impacted by confusing signals on the export of vaccines. On Monday, the Jair Bolsonaro government in Brazil dialled the Indian government after the chief of..
IndiaTimes - Published

Private hospitals, companies may get vaccine by March: Serum CEO

SII, once it rolls out the 50-60 million doses of Covishield that forms the first tranche of the govt's order, will give doses to private individuals, private hospitals and companies as early as March,..
IndiaTimes - Published

COVID-19 vaccine manufacturers must be protected from lawsuits: SII CEO Adar Poonawalla

Poonawalla made these comments at an online panel on the challenges of developing a COVID-19 vaccine at the Carnegie India's Global Technology Summit
DNA - Published

Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla


IndiaTimes - Published

SII CEO thanks PM Modi for support after seeking emergency authorisation of its Covid vaccine

After Serum Institute India (SII) applied for the emergency use authorisation of its coronavirus vaccine "COVISHIELD", its CEO Adar Poonawala expressed gratitude to Prime Minister Narendra Modi and the..
IndiaTimes - Published

COVID-19 'Virus Busters': Serum Insititute of India's Adar Poonawalla among six named 'Asians of The Year'

Poonawala joined the Serum Institute of India in 2001 and took over the day-to-day operations of the company as CEO in 2011.
DNA - Published

Formed task force in Maha to manage COVID vaccine distribution; in touch with Serum CEO: Thackeray to PM Modi

Maharashtra is in touch with Adar Poonawalla, CEO of Serum Institute of India, for coronavirus vaccine, CM Uddhav Thackeray told PM Modi.
DNA - Published

Covid vaccine should be available for public by April 2021: Serum Institute CEO

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by..
IndiaTimes - Published

India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla

SII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon.
DNA - Published

Vaccine may be ready for use as early as December: Adar Poonawalla


IndiaTimes - Published

I wish government's Covid vaccine strategy was 'Mann ki Baat': Rahul Gandhi

Gandhi's tweet came after Prime Minister Narendra Modi aired his monthly 'Mann ki baat' programme on the All India Radio (AIR). Along with his comment, Gandhi shared a news report regarding Serum..
IndiaTimes - Published

Applaud PM's vision on providing vaccines to global community: Serum's Adar Poonawalla


IndiaTimes - Published

Govt will need 80,000 crore for Covid vaccine, says Serum CEO

The government may need Rs 80,000 crore over the next one year for distribution of Covid-19 vaccine and immunization of the country’s population, Adar Poonawalla, CEO and promoter of the world’s..
IndiaTimes - Published

Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks

On September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
DNA - Published

Covid-19 vaccine by October-November: Adar Poonawalla to Naveen Patnaik

Adar Poonawalla, during an interaction with Odisha chief minister Naveen Patnaik through a video conference, expressed optimism that the Covid-19 vaccine could be ready by October-November this year..
IndiaTimes - Published